Skip to main content
Contact Us
Subscribe
E-Edition
30°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bluebird Bio
(NQ:
BLUE
)
1.440
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,283
Open
1.440
Bid (Size)
1.440 (5)
Ask (Size)
1.460 (303)
Prev. Close
1.440
Today's Range
1.440 - 1.440
52wk Range
0.8790 - 5.530
Shares Outstanding
67,578,549
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Bluebird Bio Stock Flew Higher Than the Market Today
March 18, 2024
The company was thrown a financial lifeline.
Via
The Motley Fool
bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital
March 18, 2024
From
bluebird bio, Inc.
Via
Business Wire
Performance
YTD
-2.04%
-2.04%
1 Month
+30.91%
+30.91%
3 Month
-52.79%
-52.79%
6 Month
-54.86%
-54.86%
1 Year
-67.79%
-67.79%
More News
Read More
Is Bluebird Bio Stock a Buy Now?
March 13, 2024
Via
The Motley Fool
bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy
March 11, 2024
From
bluebird bio, Inc.
Via
Business Wire
Beam Therapeutics Bolts Higher on Gene Therapy Licensing Payments
March 06, 2024
Via
MarketBeat
Forecasting The Future: 6 Analyst Projections For bluebird bio
March 05, 2024
Via
Benzinga
Why Bluebird Bio Stock Dived Into the Red on Tuesday
March 05, 2024
Via
The Motley Fool
MarketBeat Week in Review – 2/26 - 3/1
March 02, 2024
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
(BLUE) - Analyzing bluebird bio's Short Interest
February 29, 2024
Via
Benzinga
bluebird bio Stock Signals Potential to be a Multi-bagger
February 29, 2024
Via
MarketBeat
Topics
Economy
Exposures
Economy
Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug
February 27, 2024
Via
Investor's Business Daily
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Via
Benzinga
bluebird bio: How to play LEAPS options for growth and income
February 27, 2024
Via
MarketBeat
Exposures
Product Safety
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
Via
Benzinga
bluebird bio stock is ripe for a 400% institutional short squeeze
February 27, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Gene therapy: Why does it cost millions for a single treatment?
February 15, 2024
Via
MarketBeat
Exposures
Product Safety
If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today
January 27, 2024
Via
The Motley Fool
Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule
January 17, 2024
Via
Benzinga
Exposures
Product Safety
2 Red Flags for Bluebird Bio Stock
January 10, 2024
Via
The Motley Fool
2 low-priced gene therapy stocks to speculate on
January 08, 2024
Via
MarketBeat
Exposures
Product Safety
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial Outlook
January 08, 2024
From
bluebird bio, Inc.
Via
Business Wire
Better Risky Investment: Bluebird Bio vs. Shiba Inu
January 03, 2024
Via
The Motley Fool
bluebird bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
bluebird bio, Inc.
Via
Business Wire
Should You Invest in Bluebird Bio Right Now?
December 26, 2023
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.